Our group recently demonstrated part of the mechanism that mediates the activation of GPR133 (ADGRD1), a member of group V of aGPCRs (2) implicated in the pathogenesis of glioblastoma (GBM) (21, 22), an aggressive brain malignancy (23). The gene discussed is ADGRD1; the disease is glioblastoma.